Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis
- PMID: 32691881
- PMCID: PMC7404334
- DOI: 10.1002/jmv.26326
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis
Abstract
We aim to systematically review the characteristics of asymptomatic infection in the coronavirus disease 2019 (COVID-19). PubMed and EMBASE were electronically searched to identify original studies containing the rate of asymptomatic infection in COVID-19 patients before 20 May 2020. Then mate-analysis was conducted using R version 3.6.2. A total of 50 155 patients from 41 studies with confirmed COVID-19 were included. The pooled percentage of asymptomatic infection is 15.6% (95% CI, 10.1%-23.0%). Ten included studies contain the number of presymptomatic patients, who were asymptomatic at screening point and developed symptoms during follow-up. The pooled percentage of presymptomatic infection among 180 initially asymptomatic patients is 48.9% (95% CI, 31.6%-66.2%). The pooled proportion of asymptomatic infection among 1152 COVID-19 children from 11 studies is 27.7% (95% CI, 16.4%-42.7%), which is much higher than patients from all aged groups. Abnormal CT features are common in asymptomatic COVID-19 infection. For 36 patients from 4 studies that CT results were available, 15 (41.7%) patients had bilateral involvement and 14 (38.9%) had unilateral involvement in CT results. Reduced white blood cell count, increased lactate dehydrogenase, and increased C-reactive protein were also recorded. About 15.6% of confirmed COVID-19 patients are asymptomatic. Nearly half of the patients with no symptoms at detection time will develop symptoms later. Children are likely to have a higher proportion of asymptomatic infection than adults. Asymptomatic COVID-19 patients could have abnormal laboratory and radiational manifestations, which can be used as screening strategies to identify asymptomatic infection.
Keywords: COVID-19; Coronavirus disease 2019; SARS-CoV-2; asymptomatic infection; children coronavirus disease 2019; presymptomatic infection.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
Similar articles
-
Routine laboratory testing to determine if a patient has COVID-19.Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD013787. doi: 10.1002/14651858.CD013787. Cochrane Database Syst Rev. 2020. PMID: 33211319 Free PMC article.
-
Temporal changes of haematological and radiological findings of the COVID-19 infection-a review of literature.BMC Pulm Med. 2021 Jan 22;21(1):37. doi: 10.1186/s12890-020-01389-z. BMC Pulm Med. 2021. PMID: 33482780 Free PMC article.
-
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.J Korean Med Sci. 2020 Sep 21;35(37):e333. doi: 10.3346/jkms.2020.35.e333. J Korean Med Sci. 2020. PMID: 32959547 Free PMC article.
-
Clinical progression and changes of chest CT findings among asymptomatic and pre-symptomatic patients with SARS-CoV-2 infection in Wuhan, China.Expert Rev Respir Med. 2021 Mar;15(3):411-417. doi: 10.1080/17476348.2021.1840358. Epub 2020 Nov 2. Expert Rev Respir Med. 2021. PMID: 33135909
-
Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis.Am J Emerg Med. 2020 Sep;38(9):1722-1726. doi: 10.1016/j.ajem.2020.05.073. Epub 2020 May 27. Am J Emerg Med. 2020. PMID: 32738466 Free PMC article. Review.
Cited by
-
A novel comparison framework for epidemiological strategies applied to age-based restrictions versus horizontal lockdowns.Infect Dis Model. 2024 Jul 20;9(4):1301-1328. doi: 10.1016/j.idm.2024.07.002. eCollection 2024 Dec. Infect Dis Model. 2024. PMID: 39309400 Free PMC article.
-
Natural history of shedding and household transmission of severe acute respiratory syndrome coronavirus 2 using intensive high-resolution sampling.PLoS One. 2024 Jul 25;19(7):e0305300. doi: 10.1371/journal.pone.0305300. eCollection 2024. PLoS One. 2024. PMID: 39052659 Free PMC article.
-
Antibody Response after Homologous and Heterologous Prime-Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort.Vaccines (Basel). 2024 Apr 30;12(5):482. doi: 10.3390/vaccines12050482. Vaccines (Basel). 2024. PMID: 38793733 Free PMC article.
-
Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS) and the COVID-19 mapping and mitigation in schools (CoMMinS) study.PLoS One. 2024 May 22;19(5):e0303892. doi: 10.1371/journal.pone.0303892. eCollection 2024. PLoS One. 2024. PMID: 38776311 Free PMC article.
-
Measuring disease burden of dominant variants of COVID-19 in Taiwan.Heliyon. 2024 Apr 18;10(8):e29868. doi: 10.1016/j.heliyon.2024.e29868. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38681653 Free PMC article.
References
-
- WHO Coronavirus Disease (COVID‐19) Dashboard. https://covid19.who.int/
-
- Del Rio C, Malani PN. COVID‐19‐new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339‐1340. - PubMed
-
- Wang N How to conduct a meta‐analysis of proportions in R: a comprehensive tutorial. 2018.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous

